About Neuronetics (STIM)
Neuronetics, Inc. provides healthcare services. The Company develops therapies for chronic neuro health disorders. Neuronetics serves patients in the United States.
- USD4.56
- USD4.82
- USD4.48
- USD5.92
- 40.10%
- 75M
- 813.57k
- 301M
- 0.52
- 82.40%
Stock News
5 hours ago
Rivian: Near-Term Deliveries Cut Has No Bearing On R2's Future
SeekingAlpha
5 hours ago
Rates Spark: Market Discount Shifts To Un-Discounting Some Recession Risks
SeekingAlpha
6 hours ago
Uber: Accelerates AV Ambitions As Growth Shows Signs Of Stalling
SeekingAlpha
6 hours ago
The Next Frontier In Portfolio Design: Keeping Equities While Adding Gold
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
